Johnson & Johnson Innovation logo
Johnson & Johnson QuickFire Challenges

Unlocking Urologic Oncology Innovation QuickFire Challenge

Supports innovators designing bladder and prostate cancer therapies and surgical tools through a J&J urologic oncology challenge.

Between cyclesJohnson & Johnson InnovationUnited States

Johnson & Johnson Innovation, in partnership with the American Urological Association (AUA), launched the Unlocking Urologic Oncology Innovation QuickFire Challenge in April 2025 to solicit technologies improving treatment and care for patients with bladder and prostate cancers. The total prize pool reached up to $300,000 distributed across multiple awardees. Each recipient receives cash from the โ€ฆ

Funds innovations in bladder and prostate cancer therapeutics โ€” including local delivery and organ-sparing approaches โ€” and surgical technologies such as focal therapies and improved endoscopic procedures like TURBT.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Prize
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.$300K

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Guides for this application

All guides โ†’
NIH National Cancer Institute logo
Open

Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge โ€” Track 1

๐Ÿ‡บ๐Ÿ‡ธNCI ยท United States

Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.

BiotechMedtech+1
$567KNov'26
National Institutes of Health logo
Open

Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.

BiotechMedtech
$525KFeb'27
National Institutes of Health logo
Open

TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.

BiotechMedtech
$120K โ€“ $320KFeb'27
National Center for Advancing Translational Sciences logo
Closed

NIH Quantum Sensing Technology Challenge

๐Ÿ‡บ๐Ÿ‡ธNCATS ยท United States

Awards up to $1.6 million across stages for quantum-enabled biomedical sensing devices.

MedtechBiotech+1
$400K
National Center for Advancing Translational Sciences logo
Closed

NIH Quantum Computing Challenge

๐Ÿ‡บ๐Ÿ‡ธNCATS ยท United States

Awards up to $1.3 million across stages for new quantum algorithms solving biomedical problems.

MedtechBiotech+1
$300K
Massachusetts Institute of Technology logo
Open

MIT Solve Global Challenges

๐Ÿ‡บ๐Ÿ‡ธMIT ยท United States

Supports teams tackling global challenges by selecting and backing scalable ideas through MIT Solve challenge pathways.

AIBiotech+3
$10K โ€“ $150KNov'26